CDKN2A and leukemia: If NHEJ is involved, then only one event was needed to produce a double set of IGH-CEBPEand the concurrent deletion of PAX5 and CDKN2A. The occurrence of all these aberrations probably potentiated the aggressive refractory leukemia in our patient.